Nateglinide and coronary artery disease Patient Reports February 09, 2010



Nateglinide Side Effects Report #5616700-1
Nateglinide side effect was reported by a Physician from IRELAND on Jan 30, 2008. Female patient, 77 years of age, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: chest pain What is  chest pain, coronary artery disease What is  coronary artery disease, coronary artery stenosis, goitre, loss of consciousness, myocardial ischaemia, palpitations, sensation of pressure. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #4874983-X
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 28, 2005. Female patient, 76 years of age, weighting 216.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, bronchitis chronic, cholecystitis chronic, coronary artery disease What is  coronary artery disease, disease progression, dizziness What is  dizziness, dyspnoea, hypertension. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, CARDIKET, VERAPAMIL, HYPOTHIAZID, MONO MACK. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5327767-2
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on May 10, 2007. Female patient, 59 years of age, weighting 217.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, autoimmune thyroiditis, blood cholesterol increased, cardiac failure, chest pain What is  chest pain, coronary artery disease What is  coronary artery disease, dyspnoea, hepatic steatosis, high density lipoprotein decreased. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5332447-3
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on May 17, 2007. Female patient, 59 years of age, weighting 217.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, autoimmune thyroiditis, blood cholesterol increased, cardiac failure, chest pain What is  chest pain, coronary artery disease What is  coronary artery disease, dyspnoea, hepatic steatosis, high density lipoprotein decreased. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Nateglinide